Quick Takeaways
- GREAT POINT PARTNERS LLC filed SCHEDULE 13G for SCYNEXIS, Inc. Common Stock, par value $0.001 per share (SCYX).
- Disclosed ownership: 10%.
- Date of event: 31 Mar 2026.
GREAT POINT PARTNERS LLC - 31 Mar 2026 SCHEDULE 13G Report for SCYNEXIS, Inc. Common Stock, par value $0.001 per share (SCYX)
- Filing Manager
- GREAT POINT PARTNERS LLC
- Reporting Manager
- Great Point Partners, LLC
- Symbol
- SCYX
- Shares outstanding
- 79,866,997 shares
- Disclosed Ownership
- 7,978,713 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 07 Apr 2026, 16:00:18 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"GREAT POINT PARTNERS LLC disclosed 10% ownership in SCYNEXIS, Inc. Common Stock, par value $0.001 per share (SCYX) on 31 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Apr 2026, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Great Point Partners, LLC | 10% | 7,978,713 | 0 | 7,978,713 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D - Senior Managing Member | |
| Dr. Jeffrey R. Jay, M.D. | 10% | 7,978,713 | 0 | 7,978,713 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D | |
| Ms. Lillian Nordahl | 10% | 7,978,713 | 0 | 7,978,713 | /s/ Ms. Lillian Nordahl | Ms. Lillian Nordahl |